Keely Scamperle, FACHE

• Strategy and workstream lead to ensure implementation of well-designed comprehensive plan for transitioning self-pay only business platform into the reimbursement environment.
• Executive Leadership Team member working closely with BOD to guide operational strategy.
• Spearheaded innovative approaches to strategic Market Access and Reimbursement planning & execution.
• Attained 2 New Technology APC C-codes for primary endobariatric devices and procedures.
• Secured increased value pricing for key endobariatric product portfolio resulting in 28% revenue increase.
• Built high-performance teams through effective recruitment practices focused on competency alignment coupled with ongoing performance management processes.
• Designed and executed pre and post global market access strategy and health economic plans.
• Demonstrated proficient leadership skills to motivate employees and build competent teams.
• Collaborated with senior management to develop strategic initiatives and long term goals.
• Established coalition of provider, patient advocacy and specialty society support for proposed bundled payment model.
• Enhanced company profitability by implementing strategic business plans and optimizing operational processes.
• Led cross-functional teams for the successful completion of major projects, resulting in increased efficiency and customer satisfaction.
• Forged strategic partnerships with key industry stakeholders.
• Mentored junior staff members, helping them develop leadership skills and advance their careers within the organization.

• Lead and direct Medical Product Division health policy strategies and objectives
• Advanced company’s relationship-building goals and serve as primary point of contact with key decision-makers and stakeholders, including select officials and public sector agency leadership across regional, federal, state, and local boundaries
• Accountability for 20+ associates
• Formed working relationships with key professional Societies, specifically the staff and members of committees, such as Coding and Nomenclature, New Technology and Guidelines, Patient Advocacy
• Represent Gore’s voice with trade organizations including AdvaMed, MedTech Europe, MDIC, ABHI, HTAi
• Cultivated strong relationships with internal and external stakeholders, improving overall satisfaction and trust in leadership capabilities.
• Applied strong leadership talents and problem-solving skills to maintain team efficiency and organize workflows.

Global Director, Health Economics and Value Strategist – Aortic Portfolio

• Deliver expert leadership and direction in all aspects of Health Economics: health economic value, coding, coverage, policy, payment
• Achieved new CPT coding and NTAP assignments for 2 new technologies.
• Represented Gore’s interest in relevant discussions and actions with external groups, e.g. HCP-LAN, MDEpiNET, CMS, AdvaMed, specialty society, industry coalitions, etc
• Directed high-impact projects from conception to completion, consistently delivering on time and within budget constraints.
• Worked cross-functionally to further successful definition of value
• Negotiated contracts with vendors and partners, securing favorable terms that aligned with business requirements.
• Provided Value Base Assessment online interactive tool platform for AdvaMed members.
• Increased team productivity by streamlining communication and implementing effective project management strategies.
• Led cross-functional teams to achieve company-wide goals, fostering a culture of collaboration and innovation.
• Managed budgets and resources, ensuring optimal allocation towards achieving organizational objectives.

• MedTech patient access consultant
• Provided payer landscape assessments, strategic business planning roadmaps to achieve market access.
• Provided strategic roadmaps leading to market access and reimbursement outcome successes.

• Launch the company’s first Reimbursement Division
• Hired and managed a team of regional Field Reimbursement Managers and associated budgets
• Penetrated and converted non-coverage policies across all payer types for primary device platform (Mobi-C cervical disc) which leveraged subsequent acquisition.
• Increased employee satisfaction, providing regular coaching and feedback sessions.

• Develop and lead reimbursement strategy and outcomes.
• Solicited and worked with CMS to launch first HCPCS “Q” codes for skin substitutes and the AMA to establish associated CPT codes.
• Overcame universal non-coverage policies for skin substitute biologic which expanded market to 58m Medicare and over 200m Commercial covered lives.
• Attained higher DRG for total ankle replacements protecting from 30% rate decrease.
• Optimized organizational performance by designing comprehensive training programs tailored to individual needs.
• Facilitated cross-functional collaboration for improved decision-making processes within the organization.

• Direct reimbursement strategy, conduct landscape analysis, meet with all payer types.
• Conducted Federal Administrative Law Judge cases with 100% success rate on more than 200 Medicare denial cases equating to over $1.0m in revenue recapture per year.
• Federal Rule Making committee member tasked with defining “custom” spine and knee orthotic devices.
• Key company representative at Capitol Hill meetings with staff and events showcasing industry innovation.
  

Health Care Compliance Officer

• Create the company’s first Health Care Compliance program.
• Team leader and coordinator in Federal Investigation by CMS, DOJ and DOD with extremely favorable outcome that precluded the need for an on-site Federal Monitor or Corporate Integrity Agreement.
  

Appeals Specialist
• Construct appeals strategy and execution for all denials; engage in patient advocacy.
• Reversed national non-coverage policies; increased annual revenue and profit for primary technology.
• Successfully won 80% of all denials, generating ~500k/mo in lost revenue.